Morphomics predicts response to ipilimumab in patients with stage IV melanoma

Publisher: John Wiley & Sons Inc

E-ISSN: 1096-9098|22-4790|4|333-337

ISSN: 0022-4790

Source: JOURNAL OF SURGICAL ONCOLOGY, Vol.22-4790, Iss.4, 2015-08, pp. : 333-337

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract